Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edward L. Giovannucci, D.Sc., M.D.

Co-Author

This page shows the publications co-authored by Edward Giovannucci and Paul Lochhead.
Connection Strength

1.561
  1. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine. Epidemiology. 2016 07; 27(4):602-11.
    View in: PubMed
    Score: 0.167
  2. Postdiagnostic intake of one-carbon nutrients and alcohol in relation to colorectal cancer survival. Am J Clin Nutr. 2015 Nov; 102(5):1134-41.
    View in: PubMed
    Score: 0.159
  3. Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions. Am J Gastroenterol. 2014 Aug; 109(8):1205-14.
    View in: PubMed
    Score: 0.145
  4. Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression. Mod Pathol. 2015 Jan; 28(1):14-29.
    View in: PubMed
    Score: 0.145
  5. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol. 2013 Apr; 26(4):465-84.
    View in: PubMed
    Score: 0.131
  6. Frequency of Bowel Movements and Risk of Diverticulitis. Clin Gastroenterol Hepatol. 2022 02; 20(2):325-333.e5.
    View in: PubMed
    Score: 0.057
  7. Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies. Br J Cancer. 2020 09; 123(5):844-851.
    View in: PubMed
    Score: 0.055
  8. Dietary Inflammatory Potential and Risk of Crohn's Disease and Ulcerative Colitis. Gastroenterology. 2020 09; 159(3):873-883.e1.
    View in: PubMed
    Score: 0.055
  9. Healthy Lifestyle Is Associated With Reduced Mortality in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2021 01; 19(1):87-95.e4.
    View in: PubMed
    Score: 0.054
  10. Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor. Gastroenterology. 2017 12; 153(6):1517-1530.e14.
    View in: PubMed
    Score: 0.045
  11. Long-term use of antibiotics and risk of colorectal adenoma. Gut. 2018 04; 67(4):672-678.
    View in: PubMed
    Score: 0.044
  12. A Prospective Study of Smoking and Risk of Synchronous Colorectal Cancers. Am J Gastroenterol. 2017 03; 112(3):493-501.
    View in: PubMed
    Score: 0.043
  13. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes. Gastroenterology. 2016 11; 151(5):879-892.e4.
    View in: PubMed
    Score: 0.042
  14. Statistical methods for studying disease subtype heterogeneity. Stat Med. 2016 Feb 28; 35(5):782-800.
    View in: PubMed
    Score: 0.040
  15. Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status. J Natl Cancer Inst. 2016 Apr; 108(4).
    View in: PubMed
    Score: 0.040
  16. Molecular pathological epidemiology gives clues to paradoxical findings. Eur J Epidemiol. 2015 Oct; 30(10):1129-35.
    View in: PubMed
    Score: 0.040
  17. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013 Sep 19; 369(12):1095-105.
    View in: PubMed
    Score: 0.034
  18. Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA. 2013 Jun 26; 309(24):2563-71.
    View in: PubMed
    Score: 0.034
  19. Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology. Oncogene. 2014 Jun 05; 33(23):2949-55.
    View in: PubMed
    Score: 0.034
  20. A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classification. Am J Epidemiol. 2013 Jul 01; 178(1):84-100.
    View in: PubMed
    Score: 0.034
  21. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2013 Jun; 22(6):1142-52.
    View in: PubMed
    Score: 0.034
  22. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with ß-catenin (CTNNB1) status. Cancer Res. 2013 Mar 01; 73(5):1600-10.
    View in: PubMed
    Score: 0.033
  23. Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. J Natl Cancer Inst. 2013 Jan 16; 105(2):130-40.
    View in: PubMed
    Score: 0.033
  24. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med. 2012 Oct 25; 367(17):1596-606.
    View in: PubMed
    Score: 0.032
  25. Colorectal cancer: a tale of two sides or a continuum? Gut. 2012 Jun; 61(6):794-7.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.